Nevro is a medical devices business based in the US. Nevro shares (NVRO) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $4.23 – an increase of 3.93% over the previous week. Nevro employs 1,215 staff and has a trailing 12-month revenue of around $419.1 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $4.23 |
|---|---|
| 52-week range | $3.95 - $22.64 |
| 50-day moving average | $5.21 |
| 200-day moving average | $9.57 |
| Wall St. target price | $7.05 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.94 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.24 from 2024-11-19
| 1 week (2024-11-13) | -4.72% |
|---|---|
| 1 month (2024-10-18) | -21.19% |
| 3 months (2024-08-21) | -22.34% |
| 6 months (2024-05-20) | -59.70% |
| 1 year (2023-11-20) | -74.43% |
|---|---|
| 2 years (2022-11-21) | -90.14% |
| 3 years (2021-11-19) | 86.83 |
| 5 years (2019-11-21) | 106.94 |
| Revenue TTM | $419.1 million |
|---|---|
| Gross profit TTM | $276.4 million |
| Return on assets TTM | -9.02% |
| Return on equity TTM | -24.78% |
| Profit margin | -16.54% |
| Book value | $7.31 |
| Market Capitalization | $152.5 million |
TTM: trailing 12 months
We're not expecting Nevro to pay a dividend over the next 12 months.
Nevro's shares were split on a 1:24 basis on 5 November 2014 . So if you had owned 24 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nevro shares – just the quantity. However, indirectly, the new 2300% higher share price could have impacted the market appetite for Nevro shares which in turn could have impacted Nevro's share price.
Over the last 12 months, Nevro's shares have ranged in value from as little as $3.95 up to $22.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Nevro's is 0.931. This would suggest that Nevro's shares are less volatile than average (for this exchange).
Nevro Corp. , a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.